Spire Wealth Management Lantern Pharma Inc. Transaction History

Spire Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$4.82 - $7.45 $9,760 - $15,086	-2,025 Reduced 50.0%	2,025 $12,000
Q4 2021 Jan 14, 2022	BUY	$7.11 - $11.04 $21,330 - $33,120	3,000 Added 285.71%	4,050 $32,000
Q1 2021 May 21, 2021	BUY	$14.34 - $21.92 $15,057 - $23,016	1,050 New	1,050 $19,000

1.31M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $37M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.